We are a team of interdisciplinary researchers, scientists, designers and engineers, with a wide range of skills and experience. Our areas of interest include Photonics, Cancer Biology, Genetics, Nanotechnology, Electronics, Web & Mobile application development, Machine Learning and others.
We love what we do, and we do it with passion.
Dr. Swetha Bobba, PhD
CEO & Founder
Dr. Swetha B. is a PhD in Photonics (Physics) from University of London, United Kingdom.
Her expertise is in the design of Optical Waveguides and Fibres using 2D nanomaterials such as Graphene/ Molybdenum disulphide for biomedical applications using non-linear optics, and in the development of Lasers using Perovskite.
She has also worked on theoretical and experimental analysis of Polarization modulation instability (PMI), Cross-phase polarisation modulation instability (XPMI), and Dispersive Fourier Transform (DFT) at FEMTO-ST, France as part of her post-doctoral research. And, her other research interests include cancer biology, biomedicine, linear optics in waveguides/optical fibres for sensor applications, electronics, robotics and artificial intelligence (AI).
[Selected References:
- https://www.nature.com/articles/s41598-017-10141-3
- https://opg.optica.org/ol/abstract.cfm?uri=ol-45-13-3545
- https://ieeexplore.ieee.org/document/7038921%5D
Email ID: swetha.bobba.1@immortalight.com
Prof. Y.P. Bhandary, PhD
Collaborator
Dr. Bhandary is an Associate Professor at Yenepoya Research Centre, Yenepoya (Deemed to be University) where his research focuses on the role of inflammatory cytokines in regulating p53-fibrinolytic system in lung diseases. He obtained his M.Sc in Medical Biochemistry from Kasturba Medical College, Mangalore and Ph.D in Medical Biochemistry from Mahatma Gandhi Institute of Medical Sciences, Sevagram, Nagpur University, where he worked on the seroreactivity and polymorphism study of filarial parasites.
Following his Ph.D, Dr. Bhandary did his post-doctoral studies at the University of Texas Health Science Centre, Tyler, Texas, USA, on the posttranscriptional regulation of p53-fibrinolytic system in lung diseases.
Dr. Bhandary is our collaborator in the on-going SARS-CoV2 drug development project.
Prof. Kenneth Grattan, OBE FREng
Scientific Advisor
Professor Grattan graduated in Physics from Queen’s University Belfast with a BSc (First Class Honours) in 1974, followed by a PhD in Laser Physics. His doctoral research involved the use of laser-probe techniques for measurements on potential new laser systems.
Following Queen’s, in 1978 he became a Research Fellow at Imperial College of Science and Technology, sponsored by the Rutherford Laboratory to work on advanced photolytic drivers for novel laser systems. This involved detailed measurements of the characteristics and properties of novel laser species and a range of materials involved in systems calibration.
In 1983 he joined City University London as a “new blood” Lecturer in Physics, being appointed Professor of Measurement and Instrumentation in 1991 and Head of the Department of Electrical, Electronic and Information Engineering. From 2001 to 2008 he was the Associate and then Deputy Dean of the School of Engineering and from 2008 to 2012 the first Conjoint Dean of the School of Engineering & Mathematical Sciences and the School of Informatics. In 2013 he was appointed the Inaugural Dean of the City Graduate School. He was appointed George Daniels Professor of Scientific Instrumentation in 2013 and to a Royal Academy of Engineering Research Chair in 2014.
His research interests have expanded to include the development and use of fibre optic and optical systems in the measurement of a range of physical and chemical parameters. The work has been sponsored by a number of organizations including EPSRC, the EU, private industry and charitable sources, and he holds several patents for instrumentation systems for monitoring in industry using optical techniques.
Prof. Ken Grattan is the Scientific advisor for our Oral Cancer project.
Dr. Shushil Choubey, MD
Scientific Advisor
Dr. Shushil Choubey is a medical post-graduate with 20+ years of experience in the pharmaceutical/medical device industry, with experience at Regional & at Global Leadership levels in the R&D at several Global MNC’s (Novartis, Allergan, Santen Japan) & Indian BIG Pharma Companies (Dr Reddy’s, Torrent Pharma, Cadila & Piramal Healthcare). His last full time assignment was with Novartis Research & Development as Site Head, Drug Regulatory Affairs & the Sub-Regional Head (AMAC, GEM, and LACAM Regions), leading a team of more than 100 Scientists. At Novartis, he was part of Novartis Drug Regulatory Affairs Global Leadership Team. Prior to Novartis, he was with Allergan India for 4.6 years, heading the Scientific & Regulatory Affairs functions (South Asia); and Lead Pharmacovigilance for Asia. Apart from core Scientific & Regulatory Affair functions (South Asia), he was additionally responsible for Clinical, Non-Clinical and CMC aspects of Regional Product Development Initiatives.
Dr. Choubey is our Scientific advisor for the SARS-CoV2 drug development project.
Ms. Gaya, MBA
Administrator
Ms. Gaya is a MBA graduate with over 15yrs of experience in administration.
Email ID: gayatri.admin@immortalight.com
immortalight.com 